Shen Lujun相关文献与解析，生知库 | 链接生命科学的每一步

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study

NTAA预后模型在接受经动脉化疗栓塞治疗的BCLC B期肝细胞癌中的应用及验证：一项回顾性多中心队列研究

Chen, Shuanggang; Shen, Lujun; Lin, Letao; Qi, Han; Chang, Boyang; Zeng, Qi; Lu, Linbin; Huang, Jingjun; Tan, Hongtong; Cao, Fei; Xie, Lin; Huang, Tao; Wu, Ying; Wen, Chunyong; Wang, Yujia; Tang, Ruizhi; Li, Chen; Zheng, Guanglei; Nuerhashi, Gulijiayina; Fan, Weijun

NTA

Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

亚洲肝细胞癌肿瘤消融指南会议

期刊:Liver Cancer

影响因子:9.1

doi:10.1159/000544976

Shiina, Shuichiro; Tateishi, Ryosuke; Choi, Joon Il; Kim, So Yeon; Meng, Zhiqiang; Shen, Lujun; Lu, Sheng-Nan; Hwang, Jen-I; Tobari, Maki; Maruyama, Hitoshi; Batsaikhan, Terguunbileg; Deng, Qing; Canseco, Lariza Marie; Asaoka, Yoshinari; Lin, Shi-Ming; Huang, Kai-Wen; Rhim, Hyunchul; Liang, Ping; Pua, Uei; Tanaka, Masatoshi; Wu, Peihong

Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial

在巴塞罗那临床肝癌C期晚期肝细胞癌（Double-IA-001）中，采用肝动脉灌注FOLFOX化疗联合卡瑞利珠单抗和索拉非尼治疗（Double-IA-001）：一项II期临床试验

期刊:BMC Medicine

影响因子:8.3

doi:10.1186/s12916-025-04110-1

Shen, Lujun; Cao, Fei; Liu, Ying; Nuerhashi, Gulijiayina; Lin, Letao; Tan, Hontong; Wen, Chunyong; Wang, Yujia; Chen, Shuanggang; Zou, Hongliang; Xie, Lin; Fan, Weijun

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy

PD-1抑制剂增强HAIC-TKI疗法治疗伴门静脉癌栓的肝细胞癌：真实世界生存获益、安全性及亚组特异性疗效

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1602031

Cao, Fei; Wen, Chunyong; Wang, Yujia; Tan, Hongtong; Hao, Shaohuan; Chen, Jinbin; Chen, Shuanggang; Shen, Lujun; Xie, Lin; Qi, Han; Huang, Tao; Zhang, Yaojun; Huang, Zilin

The Research on Multi-Process Collaborative Manufacturing and Characterization Methods of Micro-Nano-Composite Layered Structures

微纳复合层状结构多工艺协同制造及表征方法研究

期刊:Nanomaterials

影响因子:4.3

doi:10.3390/nano15221716

Xu, Shibo; Ge, Shaobo; Sun, Zehua; Li, Junyan; Shi, Ronghua; Shen, Lujun; Zhang, Jin; Xi, Yingxue

发表日期：2025

文献求助收藏

Identification of candidates with hepatocellular carcinoma to receive TACE combined with MWA by assessing tumor burden and radiologic features

通过评估肿瘤负荷和影像学特征，筛选适合接受经导管动脉化疗栓塞术（TACE）联合微波消融术（MWA）治疗的肝细胞癌候选患者。

期刊:Therapeutic Advances in Medical Oncology

影响因子:4.2

doi:10.1177/17588359251324052

An, Chao; Shen, Lujun; Chen, Qifeng; Jiang, Yiquan; Li, Chen; Ren, He; Wu, Peihong; Liu, Xi

Association between active/passive Involution and lying flat among college students: the mediation role of perceived stress and anxiety

大学生主动/被动内卷与平躺姿势之间的关联：感知压力和焦虑的中介作用

期刊:BMC Public Health

影响因子:3.6

doi:10.1186/s12889-025-21994-z

Yang, Lei; Zhang, Yunbing; Zhang, Dongjun; Shen, Lujun; Feng, Hui

发表日期：2025

文献求助收藏

Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study

对潜在可移植患者行孤立性早期肝细胞癌（≤3 cm）消融术后，复发超出米兰标准的情况进行长期分析：一项超过10年的生存研究

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S505979

Chen, Shuanggang; Qi, Han; Tan, Hongtong; Cao, Fei; Xie, Lin; Huang, Tao; Wu, Ying; Wen, Chunyong; Wang, Yujia; Shen, Lujun; Fan, Weijun

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling.

微波消融对肝细胞癌复发和转移的影响：来自动物研究和细胞因子分析的见解

期刊:Journal of Hepatocellular Carcinoma

影响因子:3.4

doi:10.2147/JHC.S515779

Wang Yujia, Tan Hongtong, Wen Chunyong, Chen Shuanggang, Zheng Guanglei, Qi Han, Xie Lin, Shen Lujun, Cao Fei, Fan Weijun

细胞生物学

发表日期：2025

文献求助收藏

Geometry-Dependent Photonic Nanojet Formation and Arrays Coupling

几何形状相关的光子纳米射流形成和阵列耦合

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study

NTAA预后模型在接受经动脉化疗栓塞治疗的BCLC B期肝细胞癌中的应用及验证：一项回顾性多中心队列研究

Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

亚洲肝细胞癌肿瘤消融指南会议

Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial

在巴塞罗那临床肝癌C期晚期肝细胞癌（Double-IA-001）中，采用肝动脉灌注FOLFOX化疗联合卡瑞利珠单抗和索拉非尼治疗（Double-IA-001）：一项II期临床试验

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy

PD-1抑制剂增强HAIC-TKI疗法治疗伴门静脉癌栓的肝细胞癌：真实世界生存获益、安全性及亚组特异性疗效

The Research on Multi-Process Collaborative Manufacturing and Characterization Methods of Micro-Nano-Composite Layered Structures

微纳复合层状结构多工艺协同制造及表征方法研究

Identification of candidates with hepatocellular carcinoma to receive TACE combined with MWA by assessing tumor burden and radiologic features

通过评估肿瘤负荷和影像学特征，筛选适合接受经导管动脉化疗栓塞术（TACE）联合微波消融术（MWA）治疗的肝细胞癌候选患者。

Association between active/passive Involution and lying flat among college students: the mediation role of perceived stress and anxiety

大学生主动/被动内卷与平躺姿势之间的关联：感知压力和焦虑的中介作用

Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study

对潜在可移植患者行孤立性早期肝细胞癌（≤3 cm）消融术后，复发超出米兰标准的情况进行长期分析：一项超过10年的生存研究

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling.

微波消融对肝细胞癌复发和转移的影响：来自动物研究和细胞因子分析的见解